INTRODUCTION: -cancer is a terminal disease that is effecting the population today
- Leukemia is one type of cancer that currently effects 310, 046 people with an added estimated 48,610 expected to be diagnosed
- Leukaemia is a cancer of the blood and bone marrow. It causes white blood cells (also called leukocytes) to develop abnormally.
-Today’s scientists are currently looking for ways treat this deadly disease, using stem cells.
- stem cells are multicellular organism that are capable of giving rise to indefinitely more cells. Stem cells are located in the bone marrow and are create blood cells with include white blood cells, (leukocytes) which fight infections; red blood cells (erythrocytes) which carry oxygen and remove waste products from organs and tissues
-hematopoietic Progenitor Cell Transplantation treatment allows a donor who has healthy stem cells that match up with the infected patients, to transfer their stem cells to the body of the infected with an added component of chemotherapy
-this treatment helps to rid of the diseases from the patient’s body, as the transferred stem cells travel from the blood (where it was injected) to the marrow, produce while blood cells, platelets and red blood cells that are necessary for function such as immunity, clotting and oxygen transport with a chance of relapse
Thesis: This paper will discuss how Hematopoietic Progenitor Cell Transplantation is unbeneficial for today’s society. Identify Supporting Arguments: (do not list them) 3 Disadvantages: economic charge for treatment, Long-term side effects, and not finding a match You must establish briefly their connection to your thesis/claim. How do the arguments help you to prove your thesis/claim? Each argument should be presented in a separate sentence. 1st Paragraph: There has been a dramatic increase in the number of hematopoietic cell transplantation procedures performed worldwide
An increase use of this expensive treatment modality has economic consequences
According to an Agency for Health Care Research and Quality report, Hematopoietic generated the most rapid increase in total hospital cost from 2004 to 2007 with a growth rate of 84.9% and 1.3 billion dollars spent in 2007
- $36,000 to $88,000 is the price for the beginning of the hematopoietic treatment (if there are other complications, it will cost more)
-estimated 25.6% percent increase in the meann cost of hospital stays and a 59.3% increase due to the number of hospital days
-the increase attention to value this allows the hospitals to be able to carry up the procedure but they must still carefully monitor financial cost to keep everything intact and running smoothly
-the societal burden of cancer care is substantial and likely to increase with the newer treatment modalities
-the National Cancer Institute estimated 13.8 and 18.1 million cancer survivors in 2010 and 2020, respectively, with associated costs of cancer care of 125 and 158 billion 2010 US dollars